New Light Shed on Who Benefits Most From Weight-Loss Jabs
Scientists have made a significant breakthrough in understanding which patients stand to gain the most from popular weight-loss medications, with new research suggesting that a person's genetic makeup may play a crucial role in determining how effective the drugs are for them.
Research indicates that people carrying variations in two specific genes linked to appetite regulation and digestion are likely to lose more weight when taking obesity drugs compared to those without these genetic traits. The findings could mark an important step toward more personalised approaches to obesity treatment.
The development comes amid a surge in the use of weight-loss injections, with drugs such as semaglutide, sold under brand names including Ozempic and Wegovy, transforming how the medical community approaches obesity. These medications have generated enormous public interest in recent years due to their reported effectiveness in helping patients shed significant amounts of weight.
Obesity remains one of the most pressing public health challenges globally, affecting hundreds of millions of people and increasing the risk of serious conditions including type 2 diabetes, heart disease, and certain cancers. Finding ways to match patients with the most suitable treatments has long been a goal of medical researchers.
The new findings raise the possibility that genetic screening could one day be used to help doctors identify which patients are best suited to weight-loss jabs before they begin treatment. Such an approach could improve outcomes and ensure that limited and often costly medications are directed toward those most likely to benefit.
Experts have increasingly emphasised that obesity is a complex condition influenced by a wide range of biological, environmental, and psychological factors. Understanding the genetic components of how individuals respond to treatment adds another dimension to that picture and reinforces calls for tailored medical strategies rather than a one-size-fits-all approach to weight management.
